Monday, 31 August 2026European Markets

KITRON And 2 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Loading stream...

(VIANEWS) - KITRON (KIT.OL), ASML HOLDING (ASML.AS), MELEXIS (MELE.BR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. KITRON (KIT.OL)

38.7% sales growth and 24.07% return on equity

Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.

Earnings Per Share

As for profitability, KITRON has a trailing twelve months EPS of kr2.15.

PE Ratio

KITRON has a trailing twelve months price to earnings ratio of 19.77. Meaning, the purchaser of the share is investing kr19.77 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.07%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 32.4%, now sitting on 617.39M for the twelve trailing months.

Sales Growth

KITRON's sales growth is 39.3% for the present quarter and 38.7% for the next.

More news about KITRON.

2. ASML HOLDING (ASML.AS)

10.4% sales growth and 74.04% return on equity

ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

Earnings Per Share

As for profitability, ASML HOLDING has a trailing twelve months EPS of €17.38.

PE Ratio

ASML HOLDING has a trailing twelve months price to earnings ratio of 38.35. Meaning, the purchaser of the share is investing €38.35 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 74.04%.

More news about ASML HOLDING.

3. MELEXIS (MELE.BR)

10% sales growth and 41.13% return on equity

Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN transceiver, CAN transceiver, RFID Transceiver NFC Sensor tag ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.

Earnings Per Share

As for profitability, MELEXIS has a trailing twelve months EPS of €4.9.

PE Ratio

MELEXIS has a trailing twelve months price to earnings ratio of 18.19. Meaning, the purchaser of the share is investing €18.19 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 41.13%.

Volume

Today's last reported volume for MELEXIS is 7834 which is 76.35% below its average volume of 33131.

Yearly Top and Bottom Value

MELEXIS's stock is valued at €89.15 at 02:20 EST, way under its 52-week high of €106.90 and way higher than its 52-week low of €63.05.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 10, 2023, the estimated forward annual dividend rate is 4.4 and the estimated forward annual dividend yield is 4.98%.

More news about MELEXIS.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com
KITRON And 2 Other Stocks Have High Sales Growth And An Above 3% Return on Equity | ViaNews EU